7
Total deals
$248.6M
Total value
$49.7M
Avg deal
$131.6M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
CellPoint
CellPoint is an enables clinicians to treat hematological malignancies by retarg…
|
2022-06-21 | Acquisition | Complete | $131.6M | Deal → |
| 2 |
Abound Bio
Abound Bio specializes in generating antibody-based biological therapeutics to m…
|
2021-06-21 | Acquisition | Complete | $14.0M | Deal → |
| 3 |
Cangenix
Cangenix is a gene-to-structure and biophysics CRO based in the South East of th…
|
2013-01-15 | Acquisition | Complete | — | Deal → |
| 4 |
A
Argenta Discovery
Argenta Discovery is a privately held contract research drug discovery company.
|
2010-02-02 | Acquisition | Complete | — | Deal → |
| 5 |
ProStrakan
ProStrakan is a pharmaceutical company.
|
2007-01-02 | Acquisition | Complete | $41.1M | Deal → |
| 6 |
Inpharmatica
Inpharmatica specialises in the use of predictive informatics in medicinal chemi…
|
2006-12-07 | Acquisition | Complete | $25.4M | Deal → |
| 7 |
B
BioFocus DPI
BioFocus DPI develops gene-to-candidate drug discovery products and provides ser…
|
2005-09-21 | Acquisition | Complete | $36.5M | Deal → |